The CEASE-AF randomized-controlled trial demonstrated long-term durability of Hybrid ablation through 3 years of follow-up in patients with long-standing persistent Afib.
To watch Dr. Doll’s full presentation of the data, visit: <a href="https://okt.to/kbj6Qa" target="_blank">https://okt.to/kbj6Qa</a>
<a href='https://www.linkedin.com/feed/hashtag/?keywords=HybridAFTherapy&highlig…; target='_blank'>#HybridAFTherapy</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=Epeeps&highlightedUpdat…; target='_blank'>#Epeeps</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=Afib&highlightedUpdateU…; target='_blank'>#Afib</a>
